George Farmer
Stock Analyst at Scotiabank
(2.07)
# 2,838
Out of 4,734 analysts
61
Total ratings
37.5%
Success rate
-2.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $18 → $16 | $13.08 | +22.32% | 3 | Jan 8, 2025 | |
| KURA Kura Oncology | Maintains: Sector Perform | $18 → $10 | $7.26 | +37.74% | 2 | Jan 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $35 → $47 | $23.55 | +99.58% | 3 | Dec 11, 2024 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $42 → $62 | $40.72 | +52.26% | 3 | Dec 4, 2024 | |
| ARGX argenx SE | Upgrades: Sector Outperform | $439 → $715 | $640.52 | +11.63% | 5 | Nov 5, 2024 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $17 → $14 | $7.08 | +97.74% | 4 | Oct 30, 2024 | |
| AURA Aura Biosciences | Maintains: Sector Outperform | $20 → $23 | $7.77 | +196.01% | 2 | Oct 18, 2024 | |
| SKYE Skye Bioscience | Initiates: Sector Outperform | $20 | $2.66 | +651.88% | 1 | Sep 30, 2024 | |
| BMEA Biomea Fusion | Maintains: Sector Outperform | $21 → $41 | $3.98 | +931.45% | 3 | Sep 27, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $95 → $78 | $61.53 | +26.77% | 7 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $22 | $6.45 | +241.09% | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $32.66 | +132.70% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $275 → $244 | $140.55 | +73.60% | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3.15 | $0.58 | +443.20% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.90 | +348.28% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.93 | +1,304.34% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $66.48 | -0.72% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $34.06 | +220.02% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $71.93 | +20.95% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $3.94 | +737.56% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.95 | +4,097.27% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $36.20 | -25.41% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $110.05 | -31.85% | 3 | Apr 29, 2020 |
Syndax Pharmaceuticals
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $16
Current: $13.08
Upside: +22.32%
Kura Oncology
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $7.26
Upside: +37.74%
NewAmsterdam Pharma Company
Dec 11, 2024
Maintains: Sector Outperform
Price Target: $35 → $47
Current: $23.55
Upside: +99.58%
Janux Therapeutics
Dec 4, 2024
Maintains: Sector Perform
Price Target: $42 → $62
Current: $40.72
Upside: +52.26%
argenx SE
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $640.52
Upside: +11.63%
Sage Therapeutics
Oct 30, 2024
Maintains: Sector Outperform
Price Target: $17 → $14
Current: $7.08
Upside: +97.74%
Aura Biosciences
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $7.77
Upside: +196.01%
Skye Bioscience
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.66
Upside: +651.88%
Biomea Fusion
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $3.98
Upside: +931.45%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Sector Perform
Price Target: $95 → $78
Current: $61.53
Upside: +26.77%
Aug 22, 2024
Initiates: Sector Outperform
Price Target: $22
Current: $6.45
Upside: +241.09%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $32.66
Upside: +132.70%
Aug 2, 2024
Maintains: Sector Outperform
Price Target: $275 → $244
Current: $140.55
Upside: +73.60%
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.58
Upside: +443.20%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.90
Upside: +348.28%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.93
Upside: +1,304.34%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $66.48
Upside: -0.72%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $34.06
Upside: +220.02%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $71.93
Upside: +20.95%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $3.94
Upside: +737.56%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.95
Upside: +4,097.27%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $36.20
Upside: -25.41%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $110.05
Upside: -31.85%